Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...
Medindia3d
Tirzepatide: Combating Obesity, Kidney Disease, and Heart Failure Together
Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...
News-Medical.Net on MSN5d
Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...
Pharmaceutical Technology4d
ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
News Medical6d
Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF
Packer, M., et al. (2025) Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial. JACC . doi ...
EurekAlert!6d
Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year ...